Cite
HARVARD Citation
Allard, S. et al. (2018). Fetal RHD genotyping is a cost‐effective option for supporting targeted anti‐D prophylaxis in D‐negative pregnancies. BJOG. p. 1423. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Allard, S. et al. (2018). Fetal RHD genotyping is a cost‐effective option for supporting targeted anti‐D prophylaxis in D‐negative pregnancies. BJOG. p. 1423. [Online].